Paper37597697
Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents.
Johns AC and 4 others. Bioorg Med Chem Lett, 2023. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents. Papers, record 37597697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37597697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroblastoma | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Cell Differentiation | |
| Gene Library | |
| Neuronal Outgrowth |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R15 CA213199 | NCI NIH HHS | United States | R15CA213199 | PubMed and NIH | NIH RePORTER |
| R15 CA227680 | NCI NIH HHS | United States | R15CA227680 | PubMed and NIH | NIH RePORTER |
| R25 GM102783 | NIGMS NIH HHS | United States | R25GM102783 | PubMed | NIH RePORTER |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31202802 | Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/31202802 | PubMed |
| 2 | 9046328 | Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors. | J Med Chem | 1997 | https://conductscience.org/library/papers/9046328 | PubMed |
| 3 | 29018329 | CDDO and ATRA Instigate Differentiation of IMR32 Human Neuroblastoma Cells. | Front Mol Neurosci | 2017 | https://conductscience.org/library/papers/29018329 | PubMed |
| 4 | 5545265 | Differentiation of malignant to benign cells. | Cancer Res | 1971 | https://conductscience.org/library/papers/5545265 | PubMed |
| 5 | 24811707 | A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation. | Oncotarget | 2014 | https://conductscience.org/library/papers/24811707 | PubMed |
| 6 | 10519894 | Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10519894 | PubMed |
| 7 | 11668484 | Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11668484 | PubMed |
| 8 | 31404492 | Novel Endogenous Ligands of Aryl Hydrocarbon Receptor Mediate Neural Development and Differentiation of Neuroblastoma. | ACS Chem Neurosci | 2019 | https://conductscience.org/library/papers/31404492 | PubMed |
| 9 | 3685979 | Tumor cell rejection through terminal cell differentiation. | Science | 1987 | https://conductscience.org/library/papers/3685979 | PubMed |
| 10 | 25872738 | Synthetic small molecules that induce neuronal differentiation in neuroblastoma and fibroblast cells. | Mol Biosyst | 2015 | https://conductscience.org/library/papers/25872738 | PubMed |
| 11 | 30719816 | IRE1α is critical for Kaempferol-induced neuroblastoma differentiation. | FEBS J | 2019 | https://conductscience.org/library/papers/30719816 | PubMed |
| 12 | 18607002 | Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18607002 | PubMed |
| 13 | 31689507 | Differentiation of human neuroblastoma cell line IMR-32 by sildenafil and its newly discovered analogue IS00384. | Cell Signal | 2020 | https://conductscience.org/library/papers/31689507 | PubMed |
| 14 | 28891114 | Blood-Brain Barrier Permeability of Green Tea Catechin Metabolites and their Neuritogenic Activity in Human Neuroblastoma SH-SY5Y Cells. | Mol Nutr Food Res | 2017 | https://conductscience.org/library/papers/28891114 | PubMed |
| 15 | 1850498 | Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). | N Engl J Med | 1991 | https://conductscience.org/library/papers/1850498 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37597697
GET https://conductscience.org/api/papers/v1/37597697/authors